Vaginal dilator use to promote sexual wellbeing after radiotherapy in gynecological cancer survivors.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
28 Jan 2022
28 Jan 2022
Historique:
received:
22
10
2021
accepted:
06
01
2022
entrez:
28
1
2022
pubmed:
29
1
2022
medline:
3
3
2022
Statut:
ppublish
Résumé
This study investigated the efficacy of a vaginal dilator (VD) for the treatment of radiation-induced vaginal stenosis (VS) and the effect of a VD on sexual quality of life.Fifty three patients with endometrial or cervical cancers participated in this prospective observational study. All participants were treated with radical or adjuvant external beam radiotherapy and/or brachytherapy. They were routinely examined 4 times after radiotherapy (RT) and were also asked to complete a validated sexual function-vaginal changes questionnaire. SPSS version 20 and Minitab version 16 were used for the statistical analysis. The statistical significance was set at P < .05.The VS grading score decreased and the comfortably insertable VD size gradually increased throughout a year of VD use; all patients with initial grade 3 showed a VS of grade 2 after 12 months of VD use and 65.8% of the patients with initial grade 2 demonstrated a final VS of grade 1, while 77.8% of the participants who started with the first size of VD reached the third size after 12 months. Starting VD therapy ≤3 months after the end of RT was associated with a significant decrease in VS. A total of 60.9% of participants reported that they did not feel their vaginas were too small during intercourse after 12 months of dilation, whereas only 11.5% gave the same answer before starting dilation. Furthermore, 47.17% rated their satisfaction with their sexual life 5 out of 7 and only 3.77% gave a score of 3 after 12 months of dilation.Endometrial and cervical cancer survivors are encouraged to use VD to treat VS and for sexual rehabilitation after RT. This study recommends starting vaginal dilation no more than 3 months after treatment at least 2 to 3 times a week for 10 to 15 minutes over 12 months. However, larger, well-designed randomized clinical trials should be conducted to develop specific guidelines for VD use and efficacy in VS and sexual sexual quality of life after RT.
Identifiants
pubmed: 35089231
doi: 10.1097/MD.0000000000028705
pii: 00005792-202201280-00046
pmc: PMC8797530
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e28705Informations de copyright
Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors have no funding and conflicts of interests to disclose.
Références
Venkat PS, Parikh N, Beron P. Recent advances in gynecologic radiation oncology. Curr Opin Obstet Gynecol 2019;31:38–42.
Aziz M Noreen. Cancer survivorship research: State of knowledge, challenges and opportunities. Acta Oncol 2009;46:417–32.
Cerentini TM, Schlöttgen J, Rosa PV, et al. Clinical and psychological outcomes of the use of vaginal dilators after gynaecological brachytherapy: a randomized clinical trial. Adv Ther 2019;36:1936–49.
Ramaseshan AS, Felton J, Roque D, Rao G, Shipper AG, Sanses TVD. Pelvic floor disorders in women with gynecologic malignancies: a systematic review. Int Urogynecol J 2018;29:459–76.
Vinwanathan AN, Lee LJ, Eswara JR, et al. Complications of pelvic radiation in patients treated for gynecologic malignancies. Cancer 2014;120:3870–83.
Morris L, Do V, Chard J, Brand AH. Radiation-induced vaginal stenosis: current perspectives. Int J Women's Health 2017;9:273–9.
Bakker RM, Mens JWM, de Groot HE, et al. A nurse-led sexual rehabilitation intervention after radiotherapy for gynecological cancer. Support Care Cancer 2017;25:729–37.
Law E, Kelvin JF, Thom B, et al. Prospective study of vaginal dilator use adherence and efficacy following radiotherapy. Radiother Oncol 2015;116:149–55.
Decruze SB, Guthrie D, Magnani R. Prevention of vaginal stenosis in patients following vaginal brachytherapy. Clin Oncol 1999;11:46–8.
National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) version 5.0,2017. https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_5x7.pdf . Accessed December 2, 2017.
Charatsi D, Tolia M, Vanakara P, et al. Vaginal stenosis after radiation therapy for pelvic cancer: prevention and treatment options – a review of the current literature. EJGO 2019;2:185–9.
Hartman P, Diddle AW. Vaginal stenosis following irradiation therapy for carcinoma of the cervix uteri. Cancer 1972;30:426–9.
Mirabeau-Beale K, Hong TS, Niemierko A, et al. Clinical and treatment factors associated with vaginal stenosis after definitive chemoradiation for anal cancer. Pract Radiat Oncol 2015;5:e113–8.
Martins J, Vaz AF, Grion RC, Esteves SCB, Costa-Paiva L, Baccaro LF. Factors associated with changes in vaginal length and diameter during pelvic radiotherapy for cervical cancer. Arch Gynecol Obstet 2017;296:1125–33.
Lancaster L. Preventing vaginal stenosis after brachytherapy for gynaecological cancer: an overview of Australian practices. Eur J Oncol Nurs 2004;8:30–9.
Grigsby PW, Russell A, Bruner D, et al. Late injury of cancer therapy on the female reproductive tract. Int J Radiat Oncol Biol Phys 1995;31:1281–99.
Katz A, Njuguna E, Rakowsky E, Sulkes A, Sulkes J, Fenig J. Early development of vaginal shortening during radiation therapy for endometrial or cervical cancer. Int J Gynecol Cancer 2001;11:234–5.
Jeffries SA, Robinson JW, Craighead PS, et al. An effective group psychoeducational intervention for improving compliance with vaginal dilation: a randomized controlled trial. Int J Radiat Oncol Biol Phys 2006;65:404–11.
Friedman LC, Abdallah R, Schluchter M, Panneerselvam A, Kunos CA. Adherence to vaginal dilation following high dose rate brachytherapy for endometrial cancer. Int J Radiat Oncol Biol Phys 2011;80:751–7.
Robinson JW, Faris PD, Scott CB. Psychoeducational group increases vaginal dilation for younger women and reduces sexual fears for women of all ages with gynecological carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 1999;44:497–506.
Corrêa CS, Leite IC, Andrade AP, de Souza Sérgio Ferreira A, Carvalho SM, Guerra MR. Sexual function of women surviving cervical cancer. Arch Gynecol Obstet 2016;293:1053–63.
Denton AS, Maher EJ. Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapy. Cochrane Database Syst Rev 2003;(1):CD003750.
Miles T, Johnson N. Vaginal dilator therapy for women receiving pelvic radiotherapy. Cochrane Database Syst Rev 2010;(9):CD007291.
White ID, Faithfull S. Vaginal dilation associated with pelvic radiotherapy: a UK survey of current practice. Int J Gynecol Cancer 2006;16:1140–6.
International Clinical Guideline Group. International Guidelines on Vaginal Dilation After Pelvic Radiotherapy. Oxon: Owen Mumford; 2012.
Pitkin RM, VanVoorhis LW. Postirradiation vaginitis. An evaluation of prophylaxis with topical estrogen. Radiol 1971;99:417–21.
Poma PA. Postirradiation vaginal occlusion: nonoperative management. Int J Gynaecol Obstet 1980;18:90–2.
American College of Obstetricians and Gynecologists (ACOG). Practice bulletin no. 213: female sexual dysfunction. Obstet & Gynecol 2019. 134 e1–e18. https://doi.org/10.1097/AOG.0000000000003324.e1-e18
doi: 10.1097/AOG.0000000000003324.e1-e18
Jensen PT, Klee MC, Thranov I, Groenvold M. Validation of a questionnaire for self-assessment of sexual function and vaginal changes after gynaecological cancer. Psycho-Oncol 2004;13:577–92.
Gondi V, Bentzen SM, Sklenar KL, et al. Severe late toxicities following concomitant chemoradiotherapy compared to radiotherapy alone in cervical cancer: an inter-era analysis. Int J Radiat Oncol Biol Phys 2012;84:973–82.
Bahng AY, Dagan A, Bruner DW, Lin LL. Determination of prognostic factors for vaginal mucosal toxicitiy associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer. Int J Radiat Oncol Biol Phys 2012;82:667–73.
Akbaba S, Oelmann-Avendano JT, Krug D, et al. The impact of vaginal dilator use on vaginal stenosis and sexual quality of life in women treated with adjuvant radiotherapy for endometrial cancer. Strahlenther Onkol 2019; https://doi.org/10.1007/s00066-019-01466-1
doi: 10.1007/s00066-019-01466-1
Velaskar SM, Martha R, Mahantashetty U, Badakare JS, Shrivastava SK. Use of indigenous vaginal dilator in radiation induced vaginal stenosis. Indian J Occup Ther 2007;39:03–6.
Son CH, Law E, Oh JH, et al. Dosimetric predictors of radiation-induced vaginal stenosis after pelvic radiation therapy for rectal and anal cancer. Int J Radiat Oncol Biol Phys 2015;92:548–54.
Bruner DW, Lanciano R, Keegan M, Corn B, Martin E, Hanks GE. Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma. Int J Radiat Oncol Biol Phys 1993;27:825–30.
Sobotkowski J, Markowska J, Fijuth J, Pietraszek A. Preliminary results of mitomycin C local application as post-treatment prevention of vaginal radiation-induced morbidity in women with cervical cancer. Eur J Gynaecol Oncol 2006;27:356–8.
Carter J, Stabile C, Seidel B, Baser RE, Goldfarb S, Goldfrank DJ. Vaginal and sexual health treatment strategies within a female sexual program for cancer patients and survivors. J Cancer Surviv 2017;11:274–83.
van Leeuwen M, Husson O, Alberti P, et al. Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire. Health Qual Life Outcomes 2018;16:114 https://doi.org/10.1186/s12955-018-0920-0
doi: 10.1186/s12955-018-0920-0
Damast S, Jeffery DD, Son CH, et al. Literature review of vaginal stenosis and dilator use in radiation oncology. Pract Radiat Oncol 2019. e1–3.
Huffman LB, Hartenbach EM, Carter J, Rash JK, Kushner DM. Maintaining sexual health throughout gynecologic cancer survivorship: a comprehensive review and clinical guide. Gynecol Oncol 2016;140:359–68.
Hanlon A, Small W, Strauss J, et al. Dilator use following vaginal brachytherapy for endometrial cancer: a randomized feasibility and adherence study. Cancer Nurs 2018;41:200–9.
Lee Y. Patients’ perception and adherence to vaginal dilator therapy: a systematic review and synthesis employing symbolic interactionism. Patient Prefer Adherence 2018;12:551–60.